139 related articles for article (PubMed ID: 8587634)
1. Trend evaluation of aluminium in uraemic patients on chronic hemodialysis.
Di Iorio BR; Scarpino L; Bruno A; Confessore A; Gaudiano G; Altieri C; Smilari F; Papaleo D; Cosentino G; Terracciano V
Nephron; 1995; 71(4):471-2. PubMed ID: 8587634
[No Abstract] [Full Text] [Related]
2. [Aluminum concentration in blood of hemodialysis patients and its clinical importance].
Skarupskiene I; Kuzminskis V; Abdrachmanovas O; Ryselis S; Smalinskiene A; Naginiene R
Medicina (Kaunas); 2003; 39 Suppl 1():104-8. PubMed ID: 12761430
[TBL] [Abstract][Full Text] [Related]
3. Silicon in chronic hemodialysis patients.
Hosokawa S; Morinaga M; Nishitani H; Maeda T; Yoshida O
ASAIO Trans; 1987; 33(3):260-4. PubMed ID: 3314921
[No Abstract] [Full Text] [Related]
4. Level-dependent inhibitory effect of hyperaluminaemia on parathyroid hormone secretion in patients with end-stage renal failure.
Fernández E; Amoedo ML; Montoliu J
Eur J Med; 1992 Dec; 1(8):482-4. PubMed ID: 1341207
[TBL] [Abstract][Full Text] [Related]
5. [Causes of hyperaluminemia in patients maintained on hemodialysis].
Balezina OA; Ermolenko VM; Bel'skii NK; Nebol'sina LA; Segel'man VS
Ter Arkh; 1982; 54(7):85-6. PubMed ID: 7135231
[No Abstract] [Full Text] [Related]
6. Is aluminum toxicity responsible for uremic pruritus in chronic hemodialysis patients?
Friga V; Linos A; Linos DA
Nephron; 1997; 75(1):48-53. PubMed ID: 9031270
[TBL] [Abstract][Full Text] [Related]
7. Parathyroid hormone in aluminum bone disease: a comparison of parathyroid hormone assays.
Andress DL; Endres DB; Ott SM; Sherrard DJ
Kidney Int Suppl; 1986 Feb; 18():S87-90. PubMed ID: 3458004
[No Abstract] [Full Text] [Related]
8. [Clinical evaluation of osteocalcin in chronic hemodialysis patients].
Nishio S; Hayashi S; Yoshihara H; Kobayagawa H
Hinyokika Kiyo; 1989 Nov; 35(11):1839-45. PubMed ID: 2618881
[TBL] [Abstract][Full Text] [Related]
9. [Chronic aluminum intoxication in patients with terminal kidney failure on programmed hemodialysis (literature review)].
Milovanova LIu; Nikolaev AIu; Barashkov GK
Ter Arkh; 2001; 73(6):67-9. PubMed ID: 11521528
[No Abstract] [Full Text] [Related]
10. Dialysis osteomalacia and aluminum toxicity: a form of renal osteodystrophy.
Felsenfeld AJ
ANNA J; 1985 Jun; 12(3):189-91. PubMed ID: 3848318
[No Abstract] [Full Text] [Related]
11. [Determination of the plasma aluminum concentration of hemodialysis patients].
Kuleva V; Petrov I; Antonov S; Kiriakov Z
Vutr Boles; 1984; 23(2):51-5. PubMed ID: 6741112
[TBL] [Abstract][Full Text] [Related]
12. Indirect methods for the diagnosis of aluminum bone disease: plasma aluminum, the desferrioxamine infusion test, and serum iPTH.
Nebeker HG; Andress DL; Milliner DS; Ott SM; Alfrey AC; Slatopolsky EA; Sherrard DJ; Coburn JW
Kidney Int Suppl; 1986 Feb; 18():S96-9. PubMed ID: 3458006
[No Abstract] [Full Text] [Related]
13. Relationship of serum aluminum to serum creatinine and parathyroid hormone in chronic renal failure and transplant patients.
Mayor GH; Hourani MR; Makdani DD
Proc Clin Dial Transplant Forum; 1977; 7():86-90. PubMed ID: 356040
[No Abstract] [Full Text] [Related]
14. [The discrepancy on measurement of parathyroid hormone in blood under the condition of diseases in hemodialysis patients with renal insufficiency and elderly osteoporotic patients].
Ueyoshi A; Kiura Y; Ota K; Okamoto Y
Ryumachi; 1988 Oct; 28(5):324-33. PubMed ID: 3227463
[No Abstract] [Full Text] [Related]
15. [Evaluation of terminal parathormone NH2 and COOH and plasma calcitonin in the blood of uremic patients under hemodialysis therapy].
Di Landro D; Zanatta GP; Simioni N; Pinzani A; Zotti D; Perin N; Bertoli M; Naso A; Ruffatti A; Gasparotto ML
Minerva Med; 1985 Mar; 76(9-10):419-23. PubMed ID: 3982699
[No Abstract] [Full Text] [Related]
16. Artificial cells in medical applications with emphasis on hemoperfusion in aluminium removal and cross-over control clinical trial of reduced time hemoperfusion-hemodialysis.
Chang TM; Barre P; Lister C; Kuruvilla S
Contrib Nephrol; 1989; 70():237-49. PubMed ID: 2670432
[No Abstract] [Full Text] [Related]
17. Trace elements in patients on chronic hemodialysis. 1. Plasma aluminium.
Shirai T; Imori H; Konomi G; Ikuta T; Minoda H; Nakao M
Fukuoka Shika Daigaku Gakkai Zasshi; 1989; 16(1):1-10. PubMed ID: 2632285
[No Abstract] [Full Text] [Related]
18. Serum aluminum and continuous ambulatory peritoneal dialysis.
Wolf A; Graf H; Pinggera WF; Stummvoll HK; Meisinger V
Ann Intern Med; 1980 Jan; 92(1):130-1. PubMed ID: 7350863
[No Abstract] [Full Text] [Related]
19. Differences in pattern visual evoked potential (PVEP) between hemodialysis and peritoneal dialysis patients.
Storch RL; Storch S; London R; Pordy WT
Clin Electroencephalogr; 1992 Oct; 23(4):169-76. PubMed ID: 1395054
[TBL] [Abstract][Full Text] [Related]
20. Serum aluminum levels in dialysis dementia.
McKinney TD; Basinger M; Dawson E; Jones MM
Nephron; 1982; 32(1):53-6. PubMed ID: 7177277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
